SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20181971
Source:
http://linkedlifedata.com/resource/pubmed/id/20181971
Search
Subject
(
90
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0041296
,
umls-concept:C0087111
,
umls-concept:C0449243
,
umls-concept:C1704686
pubmed:issue
8
pubmed:dateCreated
2010-2-25
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00398996
pubmed:abstractText
The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/U19 AI051794-05
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-10028083
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-10628452
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-10949321
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-11274626
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-11317073
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-12546112
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-15992932
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-16267745
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-16487593
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-16885778
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-18229435
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-18520676
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-19131895
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-19191655
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-19339714
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-19361855
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-20519688
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-20527060
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-20527080
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181971-9743188
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Retroviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1533-4406
pubmed:author
pubmed-author:Abdool KarimQuarraishaQ
,
pubmed-author:Abdool KarimSalim SSS
,
pubmed-author:BamberSheilaS
,
pubmed-author:BaxterCherylC
,
pubmed-author:El-SadrWafaaW
,
pubmed-author:FriedlandGeraldG
,
pubmed-author:GengiahTanujaT
,
pubmed-author:GrayAndrewA
,
pubmed-author:GroblerAnnekeA
,
pubmed-author:KhanMuniraM
,
pubmed-author:NaidooKogieleumK
,
pubmed-author:NairGonasagrieG
,
pubmed-author:PadayatchiNesriN
,
pubmed-author:PienaarJacquelineJ
,
pubmed-author:SinghAarthiA
pubmed:copyrightInfo
2010 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
25
pubmed:volume
362
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
697-706
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed-meshheading:20181971-AIDS-Related Opportunistic Infections
,
pubmed-meshheading:20181971-Adult
,
pubmed-meshheading:20181971-Anti-Retroviral Agents
,
pubmed-meshheading:20181971-Antitubercular Agents
,
pubmed-meshheading:20181971-CD4 Lymphocyte Count
,
pubmed-meshheading:20181971-Drug Administration Schedule
,
pubmed-meshheading:20181971-Drug Therapy, Combination
,
pubmed-meshheading:20181971-Female
,
pubmed-meshheading:20181971-Follow-Up Studies
,
pubmed-meshheading:20181971-HIV
,
pubmed-meshheading:20181971-HIV Infections
,
pubmed-meshheading:20181971-Humans
,
pubmed-meshheading:20181971-Kaplan-Meier Estimate
,
pubmed-meshheading:20181971-Male
,
pubmed-meshheading:20181971-Middle Aged
,
pubmed-meshheading:20181971-Patient Compliance
,
pubmed-meshheading:20181971-RNA, Viral
,
pubmed-meshheading:20181971-Tuberculosis
,
pubmed-meshheading:20181971-Viral Load
,
pubmed-meshheading:20181971-Young Adult
pubmed:year
2010
pubmed:articleTitle
Timing of initiation of antiretroviral drugs during tuberculosis therapy.
pubmed:affiliation
Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa. caprisa@ukzn.ac.za
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, Non-P.H.S.
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't